Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 163

Results For "IP"

11174 News Found

Japanese pharma firms turn to CDMOs early as peptide complexity rises
News | April 23, 2026

Japanese pharma firms turn to CDMOs early as peptide complexity rises

Neuland Laboratories reported an uptick in peptide-related engagements from Japanese companies, particularly at the preclinical and early clinical stages


Lupin launches Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in USA
Drug Approval | April 23, 2026

Lupin launches Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in USA

The product is approved as bioequivalent to Xigduo XR for the indications outlined in the reference drug’s labelling


Medtronic launches adaptive deep brain stimulation system for Parkinson’s in India
Medical Device | April 23, 2026

Medtronic launches adaptive deep brain stimulation system for Parkinson’s in India

The system is powered by BrainSense technology, which has received approval from USFDA


Vice-President calls for integrity in medical practice at AIIMS Rishikesh convocation
Hospitals | April 23, 2026

Vice-President calls for integrity in medical practice at AIIMS Rishikesh convocation

C. P. Radhakrishnan urged graduates to uphold ethical standards and maintain a commitment to patient care


We believe in trust-driven clinical conversations to cut through medical misinformation: Saurav Kasera, Founder, CLIRNET
interviews | April 22, 2026

We believe in trust-driven clinical conversations to cut through medical misinformation: Saurav Kasera, Founder, CLIRNET

CLIRNET plans to expand globally and improve how medical knowledge is shared and used in practice


ProBioGen appoints Dr Simon Johannes Bulling as its new Chief Operating Officer
People | April 22, 2026

ProBioGen appoints Dr Simon Johannes Bulling as its new Chief Operating Officer

Bulling brings extensive experience across the biopharma and CDMO landscape, with leadership roles spanning both drug substance and drug product operations


Astellas & Pfizer win FDA priority review for bladder cancer treatment expansion
News | April 22, 2026

Astellas & Pfizer win FDA priority review for bladder cancer treatment expansion

A decision is expected by August 17, 2026 under the Prescription Drug User Fee Act timeline


India–UK life sciences research to advance through new cross-border innovation corridor
R&D | April 22, 2026

India–UK life sciences research to advance through new cross-border innovation corridor

C-CAMP–Imperial College London partnership to boost biotech research, startup exchange, and translational innovation through a five-year collaboration


Crown Bioscience partners with Turbine to accelerate translational oncology research
R&D | April 22, 2026

Crown Bioscience partners with Turbine to accelerate translational oncology research

The collaboration underscores a broader industry shift toward hybrid research models that integrate computational biology with advanced experimental systems


New brain study reveals why alcohol relapse remains a persistent challenge
R&D | April 22, 2026

New brain study reveals why alcohol relapse remains a persistent challenge

These findings help explain how relapse-triggering memories can persist alongside those that support recovery